应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
TVGN Tevogen Bio Holdings
盘后交易 09-26 17:44:47 EDT
0.4099
-0.0130
-3.07%
盘后
0.4280
+0.0181
+4.42%
16:13 EDT
最高
0.4350
最低
0.3966
成交量
12.21万
今开
0.4170
昨收
0.4229
日振幅
9.08%
总市值
6,995万
流通市值
570.92万
总股本
1.71亿
成交额
4.97万
换手率
0.88%
流通股本
1,393万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Tevogen Bio Holdings Inc.盘中异动 早盘大幅拉升6.91%报0.489美元
市场透视 · 09-17
Tevogen Bio Holdings Inc.盘中异动 早盘大幅拉升6.91%报0.489美元
Tevogen Bio Holdings Inc.盘中异动 急速下跌6.28%报0.464美元
市场透视 · 09-13
Tevogen Bio Holdings Inc.盘中异动 急速下跌6.28%报0.464美元
Tevogen Bio Holdings Inc - 考虑股份回购
智通财经 · 07-12
Tevogen Bio Holdings Inc - 考虑股份回购
Tevogen Bio Holdings-提交S-1表格的注册申明以注册现有证券持有人持有的普通股和认股权的转售。
智通财经 · 06-27
Tevogen Bio Holdings-提交S-1表格的注册申明以注册现有证券持有人持有的普通股和认股权的转售。
公司概况
公司名称:
Tevogen Bio Holdings
所属市场:
NASDAQ
上市日期:
--
主营业务:
Tevogen Bio Holdings Inc.于2021年4月21日在开曼群岛注册成立,后合并重组为特拉华州公司。Tevogen Bio是一家临床阶段的专业免疫疗法公司,利用自然界最强大的免疫武器之一—CD8 +细胞毒性T淋巴细胞,开发现成的、未经基因改造的精准T细胞疗法,用于治疗传染病、癌症和神经系统疾病,旨在解决大量患者群体的重大未满足需求。
发行价格:
--
{"stockData":{"symbol":"TVGN","market":"US","secType":"STK","nameCN":"Tevogen Bio Holdings","latestPrice":0.4099,"timestamp":1727380800000,"preClose":0.4229,"halted":0,"volume":122088,"hourTrading":{"tag":"盘后","latestPrice":0.428,"preClose":0.4099,"latestTime":"16:13 EDT","volume":591,"amount":242.26901415,"timestamp":1727381606684},"delay":0,"floatShares":13928231,"shares":170646864,"eps":-1.351863,"marketStatus":"盘后交易","marketStatusCode":4,"change":-0.013,"latestTime":"09-26 17:44:47 EDT","open":0.417,"high":0.435,"low":0.3966,"amount":49746.922662,"amplitude":0.090802,"askPrice":0.428,"askSize":1560,"bidPrice":0.4,"bidSize":807,"shortable":3,"etf":0,"ttmEps":-1.351863,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1727395200000},"adr":0,"adjPreClose":0.4229,"preHourTrading":{"tag":"盘前","latestPrice":0.4351,"preClose":0.4229,"latestTime":"08:09 EDT","volume":5,"amount":2.1802999,"timestamp":1727352560898},"postHourTrading":{"tag":"盘后","latestPrice":0.428,"preClose":0.4099,"latestTime":"16:13 EDT","volume":591,"amount":242.26901415,"timestamp":1727381606684},"volumeRatio":0.830509},"requestUrl":"/m/hq/s/TVGN/wiki","defaultTab":"wiki","newsList":[{"id":"2468576533","title":"Tevogen Bio Holdings Inc.盘中异动 早盘大幅拉升6.91%报0.489美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468576533","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468576533?lang=zh_cn&edition=full","pubTime":"2024-09-17 21:48","pubTimestamp":1726580903,"startTime":"0","endTime":"0","summary":"北京时间2024年09月17日21时48分,Tevogen Bio Holdings Inc.股票出现波动,股价大幅拉升6.91%。截至发稿,该股报0.489美元/股,成交量2.6205万股,换手率0.02%,振幅3.28%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.86%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409172148249719b89d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409172148249719b89d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2467773948","title":"Tevogen Bio Holdings Inc.盘中异动 急速下跌6.28%报0.464美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2467773948","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467773948?lang=zh_cn&edition=full","pubTime":"2024-09-13 21:39","pubTimestamp":1726234766,"startTime":"0","endTime":"0","summary":"北京时间2024年09月13日21时39分,Tevogen Bio Holdings Inc.股票出现波动,股价急速下跌6.28%。截至发稿,该股报0.464美元/股,成交量2524股,换手率0.00%,振幅5.35%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.20%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240913213926a1da3275&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240913213926a1da3275&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2450981513","title":"Tevogen Bio Holdings Inc - 考虑股份回购","url":"https://stock-news.laohu8.com/highlight/detail?id=2450981513","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450981513?lang=zh_cn&edition=full","pubTime":"2024-07-12 00:23","pubTimestamp":1720715002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","TVGN"],"gpt_icon":0},{"id":"2446150003","title":"Tevogen Bio Holdings-提交S-1表格的注册申明以注册现有证券持有人持有的普通股和认股权的转售。","url":"https://stock-news.laohu8.com/highlight/detail?id=2446150003","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446150003?lang=zh_cn&edition=full","pubTime":"2024-06-27 00:49","pubTimestamp":1719420569,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["TVGN","161027","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://semperparatusspac.com","stockEarnings":[{"period":"1week","weight":-0.0224},{"period":"1month","weight":-0.2219},{"period":"3month","weight":-0.4207},{"period":"6month","weight":-0.8872},{"period":"1year","weight":-0.9609},{"period":"ytd","weight":-0.962}],"compareEarnings":[{"period":"1week","weight":0.0154},{"period":"1month","weight":0.0165},{"period":"3month","weight":0.0433},{"period":"6month","weight":0.0898},{"period":"1year","weight":0.3385},{"period":"ytd","weight":0.1993}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Tevogen Bio Holdings Inc.于2021年4月21日在开曼群岛注册成立,后合并重组为特拉华州公司。Tevogen Bio是一家临床阶段的专业免疫疗法公司,利用自然界最强大的免疫武器之一—CD8 +细胞毒性T淋巴细胞,开发现成的、未经基因改造的精准T细胞疗法,用于治疗传染病、癌症和神经系统疾病,旨在解决大量患者群体的重大未满足需求。","exchange":"NASDAQ","name":"Tevogen Bio Holdings","nameEN":"Tevogen Bio Holdings"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.28.0","shortVersion":"4.28.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tevogen Bio Holdings(TVGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Tevogen Bio Holdings(TVGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Tevogen Bio Holdings,TVGN,Tevogen Bio Holdings股票,Tevogen Bio Holdings股票老虎,Tevogen Bio Holdings股票老虎国际,Tevogen Bio Holdings行情,Tevogen Bio Holdings股票行情,Tevogen Bio Holdings股价,Tevogen Bio Holdings股市,Tevogen Bio Holdings股票价格,Tevogen Bio Holdings股票交易,Tevogen Bio Holdings股票购买,Tevogen Bio Holdings股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tevogen Bio Holdings(TVGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Tevogen Bio Holdings(TVGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}